Evommune, Inc. (EVMN) reporting calendar
Evommune, Inc. files periodic reports with the SEC as EVMN on NYSE. Atlas tracks 3 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 3
Open EVMN market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-211963 |
| 10-K | 31 Dec 2025 | 5 Mar 2026 | 64 days | 0001193125-26-093932 |
| 10-Q | 30 Sep 2025 | 11 Dec 2025 | 72 days | 0001193125-25-315972 |
Source: SEC EDGAR company submissions for CIK 0002044725. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.